Low-cost CD4 enumeration in HIV-infected patients in Thailand

Asian Pacific Journal of Allergy and Immunology

Volumn 21, Issue 2, 2003, Pages 105-113

  Pattanapanyasat, Kovit ^a   Lerdwana, Surada ^a   Shain, Hla ^b   Noulsri, Egarit ^a   Thepthai, Charin ^c   Prasertsilpa, Varipin ^b   Eksaengsri, Achara ^b   Kraisintu, Krisana ^b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b Thailand Government Pharmaceutical Organization   (Thailand)

^c MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 MONOCLONAL ANTIBODY; FLUORESCEIN ISOTHIOCYANATE; IMMUNOGLOBULIN G1 MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD3; MONOCLONAL ANTIBODY CD45; OKT 4; OKT 8; PERIDININ CHLOROPHYLL PROTEIN; PHYCOERYTHRIN; REAGENT; UNCLASSIFIED DRUG;

ARTICLE; BIOMEDICAL TECHNOLOGY ASSESSMENT; BLOOD DONOR; COLORIMETRY; COMPUTER PROGRAM; CONTROLLED STUDY; CORRELATION COEFFICIENT; COST BENEFIT ANALYSIS; DEVICE; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; FLOW CYTOMETRY; HEALTH CARE COST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGICAL MONITORING; INTERMETHOD COMPARISON; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MORPHOMETRICS; POPULATION RESEARCH; RELIABILITY; SEROPREVALENCE; STATISTICAL ANALYSIS; T LYMPHOCYTE; THAILAND;

ADULT; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FLOW CYTOMETRY; HIV INFECTIONS; HIV-1; HUMANS; MIDDLE AGED; MONITORING, IMMUNOLOGIC; REPRODUCIBILITY OF RESULTS; STATISTICS; T-LYMPHOCYTE SUBSETS; THAILAND;

EID: 0242610778     PISSN: 0125877X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Wangroongsarb Y, Weniger BG, Wasi C. Prevalence of HTLV-III/LAV antibody in selected populations in Thailand. Southeast Asian J Trop Med Public Health 1985; 16: 517-20.
2. Thai Working Group on HIV/AIDS Projection: Projections for HIV/AIDS in Thailand: 2000-2020. Ministry of Public Health, Bangkok, 2001.
3. Fahey JL, Taylor JMG, Detels R, Hofmann B. Melmed R, Nishanian P, Giorgi JV. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. N Eng J Med 1990; 322: 166-72.
4. Fauci AS, Macher AM, Longo DL, Lane HC, Rook AH, Masur H, Gelmann EP. Acquired immunodeficiency syndrome: Epidemiologic, clinical, immunologic, and therapeutic consideration. Ann Intern Med 1984; 100: 92-106.
5. Giorgi JV, Detels R. T-cell subset alterations in HIV-infected homosexual men: NIAID multicenter AIDS cohort study. Clin Immunol Immunopathol 1989; 52: 10-8.
6. Cozzi Lepri A, Phillips AN, D'Arminio Monforte A, Castelli F, Antinori A, De Luca A, Pezzotti P, Alberici F, Cargnel A, Grima P, Piscopo R, Prestileo T, Scalise G, Vigevani M, Moroni, M. When to start highly active antiretroviral therapy in chronically HIV-infected patients. Evidence from the ICONA study. AIDS 2001; 15: 983-90.
7. Miller V, Staszewski S, Sabin C, Carlebach A, Rottmann C, Weidmann E, Rabenau H, Hill A, Lepri AC, Phillips AN. CD4 lymphocyte count as a predictor of the duration of highly active antiretroviral therapy: Induced suppression of human immunodeficiency virus load. J Infect Dis 1999; 180: 530-33.
8. Centers for Disease Control and Prevention. 1997 revised guidelines for performing CD4+ T-cell determinations in persons infected with human immunodeficiency virus (HIV). MMWR 1997; 46(RR-2): 1-29.
9. Nicholson JKA, Jones BM, Hubbard M. CD4 T-lymphocyte determinations on whole blood specimens using a single-tube three-color assay. Cytometry 1993; 14: 685-89.
10. Nicholson J, Kidd P, Mandy F, Livnat D, Kagan J. Three-color supplement to the NIAID DAIDS guideline for flow cytometric immunophenotyping. Cytometry 1996; 26: 227-30.
11. Pattanapanyasat K, Kyle DE, Tongtawe P, Yongvanitchit K, Fucharoen S. Flow cytometric immunophenotyping of lymphocyte subsets in samples that contain a high proportion of nonlymphoid cells. Cytometry 1994; 18; 199-208.
12. Centers for Disease Control and Prevention. 2003 Guidelines for performing single-platform absolute CD4+ T-cell determinations with CD45 gating for persons infected with human immunodeficiency virus. MMWR 2003; 52 (RR02): 1-13.
13. Janossy G, Jani IV, Gohde W. Affordable CD4+ T-cell counts on "single platform" flow cytometers I. Primary CD4 gating. Br J Haematol 2000; 111: 1198-208.
14. Glencross D, Scott LE, Jani IV, Barnett D, Janossy G. CD45-assisted panLeucogating for accurate cost-effective dual-platform CD4+ T-cell enumeration. Cytometry 2002; 50: 69-77.
15. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods for clinical measurement. Lancet 1986; 8: 307.
16. Brando B, Barnett D, Janossy G, Mandy F, Autran B, RotheG, Scarpati B, D'Avanzo G, D'Hautcourt JL, Lenkei R, Schmitz G, Kunkl A, Chianese R, Papa S, Gratama JW. Cytofluorometric methods for assessing absolute numbers of cell subsets in blood. European Working Group on Clinical Cell Analysis (EWGCCA). Cytometry 2000; 42: 327-46.
17. Loken MR, Brosnan JM, Bach BA, Ault KA. Establishing optimal lymphocyte gates for immunophenotyping by flow cytometry. Cytometry 1990; 11: 453-59.
18. Jani I, Janossy G, Iqbal A, Mhalu FS, Lyamuya EF, Biberfeld G, Glencross D, Scott L, Reilly JT, Granger V, Barnett D. Affordable CD4+ T cell counts on "single-platform" flow cytometers. II. The use of fixed whole blood in resource poor settings. J Immunol Methods 2001; 257: 145-54.
19. Sherman GG, Galpin JS, Patel JM, Mendelow BV, Glencross DK. CD4+ T cell enumeration in HIV infection with limited resources. J Immunol Methods 1999; 222: 209-17.